These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18691164)

  • 1. Cytotoxic T lymphocytes as immune-therapy in haematological practice.
    Leen AM; Heslop HE
    Br J Haematol; 2008 Oct; 143(2):169-79. PubMed ID: 18691164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-Specific T Cells: Broadening Applicability.
    Barrett AJ; Prockop S; Bollard CM
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):13-18. PubMed ID: 29032062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.
    Micklethwaite K; Hansen A; Foster A; Snape E; Antonenas V; Sartor M; Shaw P; Bradstock K; Gottlieb D
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):707-14. PubMed ID: 17531781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant.
    Comoli P; Basso S; Labirio M; Baldanti F; Maccario R; Locatelli F
    Blood Cells Mol Dis; 2008; 40(1):68-70. PubMed ID: 17904879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients.
    Baugh KA; Tzannou I; Leen AM
    Curr Opin Infect Dis; 2018 Aug; 31(4):292-300. PubMed ID: 29750672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell therapy for viral infections.
    Heslop HE; Leen AM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():342-7. PubMed ID: 24319202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant.
    Sili U; Leen AM; Vera JF; Gee AP; Huls H; Heslop HE; Bollard CM; Rooney CM
    Cytotherapy; 2012 Jan; 14(1):7-11. PubMed ID: 22172091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation.
    Kaeuferle T; Krauss R; Blaeschke F; Willier S; Feuchtinger T
    J Hematol Oncol; 2019 Feb; 12(1):13. PubMed ID: 30728058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive cellular immunotherapy for viral diseases.
    Fujita Y; Rooney CM; Heslop HE
    Bone Marrow Transplant; 2008 Jan; 41(2):193-8. PubMed ID: 17982497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive immunotherapy for posttransplantation viral infections.
    Bollard CM; Kuehnle I; Leen A; Rooney CM; Heslop HE
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):143-55. PubMed ID: 14993880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections.
    Gerdemann U; Keirnan JM; Katari UL; Yanagisawa R; Christin AS; Huye LE; Perna SK; Ennamuri S; Gottschalk S; Brenner MK; Heslop HE; Rooney CM; Leen AM
    Mol Ther; 2012 Aug; 20(8):1622-32. PubMed ID: 22801446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.
    Peggs KS; Verfuerth S; Pizzey A; Khan N; Guiver M; Moss PA; Mackinnon S
    Lancet; 2003 Oct; 362(9393):1375-7. PubMed ID: 14585640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid salvage treatment with virus-specific T cells for therapy-resistant disease.
    Uhlin M; Gertow J; Uzunel M; Okas M; Berglund S; Watz E; Brune M; Ljungman P; Maeurer M; Mattsson J
    Clin Infect Dis; 2012 Oct; 55(8):1064-73. PubMed ID: 22806594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients.
    Savoldo B; Heslop HE; Rooney CM
    Leuk Lymphoma; 2000 Nov; 39(5-6):455-64. PubMed ID: 11342329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of cytomegalovirus/Epstein-Barr virus-specific immune effector cells for therapeutic and preventive/preemptive treatment of pediatric allogeneic cell transplant recipients.
    Dong L; Gao ZY; Chang LJ; Liang Y; Tan XY; Liu JH; Yu XJ; Yang FH; Xie Y; Lu DP
    J Pediatr Hematol Oncol; 2010 Jan; 32(1):e31-7. PubMed ID: 20051775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive immunotherapy with virus-specific T cells.
    Fuji S; Kapp M; Grigoleit GU; Einsele H
    Best Pract Res Clin Haematol; 2011 Sep; 24(3):413-9. PubMed ID: 21925094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials with CMV-specific T cells.
    Peggs KS; Mackinnon S
    Cytotherapy; 2002; 4(1):21-8. PubMed ID: 11953038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immune therapy for viral infections in transplant patients.
    Khanna R; Smith C
    Indian J Med Res; 2013 Nov; 138(5):796-807. PubMed ID: 24434332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells for viral infections after allogeneic hematopoietic stem cell transplant.
    Bollard CM; Heslop HE
    Blood; 2016 Jun; 127(26):3331-40. PubMed ID: 27207801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell Transplantation.
    Ottaviano G; Chiesa R; Feuchtinger T; Vickers MA; Dickinson A; Gennery AR; Veys P; Todryk S
    Cells; 2019 Jan; 8(1):. PubMed ID: 30646564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.